Lividomycin
| Code | Size | Price |
|---|
| TAR-T32801-5mg | 5mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Lividomycin is a representative of the pseudo-tetrasaccharide group among the NEO-type AGAs.
CAS:
11111-23-2
Formula:
C29H55N5O18
Molecular Weight:
761.776
Purity:
0.98
SMILES:
NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)C[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O
References
1. Clausnitzer D, Piepersberg W, Wehmeier UF. The oxidoreductases LivQ and NeoQ are responsible for the different 6'-modifications in the aminoglycosides lividomycin and neomycin. J Appl Microbiol. 2011 Sep;111(3):642-51. doi: 10.1111/j.1365-2672.2011.05082.x. Epub 2011 Jul 12. PubMed PMID: 21689223.
2. Kobayashi F, Yamaguchi M, Mitsuhashi S. Activity of lividomycin against Pseudomonas aeruginosa: its inactivation by phosphorylation induced by resistant strains. Antimicrob Agents Chemother. 1972 Jan;1(1):17-21. PubMed PMID: 4207755; PubMed Central PMCID: PMC444159.
3. Mori T, Kyotani Y, Watanabe I, Oda T. Chemical conversion of lividomycin A into lividomycin B. J Antibiot (Tokyo). 1972 Feb;25(2):149-50. PubMed PMID: 5034809.
4. Yamaguchi M, Koshi T, Kobayashi F, Mitsuhashi S. Phosphorylation of lividomycin by Escherichia coli carrying an R factor. Antimicrob Agents Chemother. 1972 Sep;2(3):142-6. PubMed PMID: 4597704; PubMed Central PMCID: PMC444281.